Literature DB >> 21734174

Development of newborn and infant vaccines.

Guzman Sanchez-Schmitz1, Ofer Levy.   

Abstract

Vaccines for early-life immunization are a crucial biomedical intervention to reduce global morbidity and mortality, yet their developmental path has been largely ad hoc, empiric, and inconsistent. Immune responses of human newborns and infants are distinct and cannot be predicted from those of human adults or animal models. Therefore, understanding and modeling age-specific human immune responses will be vital to the rational design and development of safe and effective vaccines for newborns and infants.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21734174      PMCID： PMC4108897          DOI： 10.1126/scitranslmed.3001880

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  76 in total

1.  Pertussis immunization in pediatric practice and in public health.

Authors:  R W PROVENZANO; L H WETTERLOW; J IPSEN
Journal:  N Engl J Med       Date:  1959-09-03       Impact factor: 91.245

2.  Whooping cough outbreak hits several US states.

Authors:  Bob Roehr
Journal:  BMJ       Date:  2010-08-24

Review 3.  The success and failure of BCG - implications for a novel tuberculosis vaccine.

Authors:  Peter Andersen; T Mark Doherty
Journal:  Nat Rev Microbiol       Date:  2005-08       Impact factor: 60.633

Review 4.  Cytokine network at the feto-maternal interface.

Authors:  S Saito
Journal:  J Reprod Immunol       Date:  2000-07       Impact factor: 4.054

Review 5.  Vaccine responsiveness in premature infants.

Authors:  David Baxter
Journal:  Hum Vaccin       Date:  2010-06-01

6.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.

Authors:  B Bourdin Trunz; Pem Fine; C Dye
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

7.  Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.

Authors:  Nicholas Wood; Peter McIntyre; Helen Marshall; Don Roberton
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

8.  Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life.

Authors:  M E Belderbos; G M van Bleek; O Levy; M O Blanken; M L Houben; L Schuijff; J L L Kimpen; L Bont
Journal:  Clin Immunol       Date:  2009-08-03       Impact factor: 3.969

Review 9.  Systems vaccinology.

Authors:  Bali Pulendran; Shuzhao Li; Helder I Nakaya
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

10.  Neonatal administration of rhesus rotavirus tetravalent vaccine.

Authors:  Timo Vesikari; Aino Karvonen; Bruce D Forrest; Yasutaka Hoshino; Robert M Chanock; Albert Z Kapikian
Journal:  Pediatr Infect Dis J       Date:  2006-02       Impact factor: 2.129
View more
  42 in total

Review 1.  Role of innate immunity in neonatal infection.

Authors:  Alex G Cuenca; James L Wynn; Lyle L Moldawer; Ofer Levy
Journal:  Am J Perinatol       Date:  2013-01-07       Impact factor: 1.862

2.  Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis.

Authors:  Cheryl B Lin; Christoph P Hornik; Reese Clark; C Michael Cotten; Daniel K Benjamin; Michael Cohen-Wolkoweiz; P Brian Smith; James L Wynn
Journal:  Early Hum Dev       Date:  2012-07-27       Impact factor: 2.079

3.  TREM-1 as a potential therapeutic target in neonatal sepsis.

Authors:  Lei Qian; Xiao-Wen Weng; Wei Chen; Chang-Hong Sun; Jian Wu
Journal:  Int J Clin Exp Med       Date:  2014-07-15

Review 4.  A prime time for trained immunity: innate immune memory in newborns and infants.

Authors:  Ofer Levy; James L Wynn
Journal:  Neonatology       Date:  2013-12-18       Impact factor: 4.035

5.  In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant.

Authors:  Simon D van Haren; Lakshmi Ganapathi; Ilana Bergelson; David J Dowling; Michaela Banks; Ronald C Samuels; Steven G Reed; Jason D Marshall; Ofer Levy
Journal:  Cytokine       Date:  2016-04-12       Impact factor: 3.861

6.  Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.

Authors:  Fernando P Polack; Shari L Lydy; Sok-Hyong Lee; Paul A Rota; William J Bellini; Robert J Adams; Harriet L Robinson; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

7.  Early sepsis does not increase the risk of late sepsis in very low birth weight neonates.

Authors:  James L Wynn; Nellie I Hansen; Abhik Das; C Michael Cotten; Ronald N Goldberg; Pablo J Sánchez; Edward F Bell; Krisa P Van Meurs; Waldemar A Carlo; Abbot R Laptook; Rosemary D Higgins; Daniel K Benjamin; Barbara J Stoll
Journal:  J Pediatr       Date:  2013-01-05       Impact factor: 4.406

8.  Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice.

Authors:  Elinor Willis; Norbert Pardi; Kaela Parkhouse; Barbara L Mui; Ying K Tam; Drew Weissman; Scott E Hensley
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

Review 9.  Antenatal immunization.

Authors:  Chrissie Jones; Paul Heath
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 10.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.